Brokerages Set ProQR Therapeutics (NASDAQ:PRQR) PT at $8.75
Shares of ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) have been assigned an average rating of “Buy” from the eight analysts that are presently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month price […]
Shares of ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) have been assigned an average rating of “Buy” from the eight analysts that are presently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month price […]
